Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 184

The DOI matches its Crossref record.

Neurofibromatosis: Phenotype, Natural History and Pathogenesis

· 2000 · Neurology

Abstract

This is the third edition of a very reputable book that was first written by Vincent Riccardi and Jan Eichner in 1986, prior to the molecular explosion in human genetics. The first edition represented the most comprehensive review of neurofibromatosis (NF) literature at that time, with proposed categorization based on the variable expression seen in these disorders. The second edition (written by Riccardi in 1992) was also a seminal volume, in terms of medical literature review by organ system, insight about underlying mechanisms, and information about the newly cloned NF1 gene. For the third edition, Dr. Riccardi is joined by three well-respected physician-scientists (Jan Friedman, David Gutmann, and Mia MacCollin) as editors. This edition is a welcome update, but it has diverged in format. Instead of one author writing multiple sections based mostly on organ systems, the medical information is somewhat reorganized into chapters written by contributing authors, all of whom are active, established investigators (and, in nearly all cases, physicians) in NF. This altered structure was likely necessary because of the vast increase in knowledge in the NF1 and NF2 fields. To include this new information, the pages devoted to clinical descriptions have been reduced, to focus on the most important and well-described medical aspects of NF; however, coverage of the relevant genetic and cell biology advances in both NF1 and NF2 has increased. Furthermore, in the second edition, all the references were listed together alphabetically at the back of the book, providing a single, large literature-search listing. In the third edition, the references are placed at the end of each chapter, which is traditional for multiauthored books but not quite as helpful for some uses. It is very difficult for any physician or investigator to be familiar with all the NF1 and NF2 literature, since there are literally hundreds of articles, across the spectrum of work, being published each year. Overall, the authors do a creditable job of referencing and summarizing the most current and medically relevant progress, given that, because of space issues, only a portion of the relevant NF literature can be discussed. This volume provides excellent illustrations of clinical features and clinical and scientific data. Some of the chapters offer “future directions” (or similar reference to needs and directions of clinical and basic research). These paragraphs provide an insightful overview on what is known and what we need to know. lso included are recommendations from clinical task forces that have been created to specifically study areas such as pilocytic astrocytoma (optic-pathway glioma) in NF1. Recent clinical data from NF databases, which contain information from many patients, are provided to add to the current literature and to increase confidence in clinically relevant statistics, such as frequencies of features and severity. Thus, this book will likely be widely used by physicians in all specialties, as the most current guideline for clinical management of NF and as a source for finding further information. To summarize the current understanding of cognitive deficits in NF1, an understanding that is greatly expanded compared with the prior edition, the chapter by Kathryn North draws cognitive and molecular/pathogenetic/animal model data together. This will benefit researchers as well as professionals such as psychologists and educators. Investigators in the many areas of NF1 and NF2 research will also find this to be a useful reference, since it is the most up-to-date publication bringing together clinical data and basic science knowledge. There are a few other helpful touches, such as David Viskochil's glossary at the end of the NF1-gene chapter. Although this work is not primarily intended for a lay audience, some features were designed for the public (e.g., the Appendix lists resources [including Web sites] for patients). Given both the relatively high frequency of NF in the general population and the increasing recognition of and interest in these disorders, this book will effectively serve both professionals and patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1212/wnl.55.2.325

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 184

Metadata

Venue
Neurology
Published
2000-07-25
Volume
55
Issue
2
Pages
325-325
ISSN
  • 0028-3878 (ISSN-L)
  • 1526-632X
OpenAlex
W1516965559
Cited by
184
References
0
FWCI
6.19
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Neurofibromatosis: Phenotype, Natural History and Pathogenesis. https://app.cochat.ai/papers/10.1212/wnl.55.2.325
The paper
Neurofibromatosis: Phenotype, Natural History and Pathogenesis. (2000). Neurology. https://doi.org/10.1212/wnl.55.2.325

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.